CATALYST BIOSCIENCES INC's ticker is CBIO and the CUSIP is 14888D208. A total of 93 filers reported holding CATALYST BIOSCIENCES INC in Q1 2021. The put-call ratio across all filers is 0.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $32,000 | +166.7% | 18,000 | 0.0% | 0.01% | +225.0% |
| Q1 2022 | $12,000 | -25.0% | 18,000 | 0.0% | 0.00% | -20.0% |
| Q4 2021 | $16,000 | -90.8% | 18,000 | -57.1% | 0.01% | -94.0% |
| Q3 2021 | $173,000 | -4.9% | 42,000 | 0.0% | 0.08% | +16.9% |
| Q2 2021 | $182,000 | -5.2% | 42,000 | +10.5% | 0.07% | -12.3% |
| Q1 2021 | $192,000 | – | 38,000 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 471,448 | $5,502,000 | 3.04% |
| ACUTA CAPITAL PARTNERS, LLC | 830,000 | $9,686,000 | 1.72% |
| NEXTHERA CAPITAL LP | 786,865 | $9,183,000 | 1.42% |
| Ghost Tree Capital, LLC | 355,000 | $4,143,000 | 1.22% |
| Point72 Europe (London) LLP | 83,500 | $974,000 | 0.52% |
| Virtus ETF Advisers LLC | 31,061 | $362,000 | 0.32% |
| Eventide Asset Management | 246,000 | $2,871,000 | 0.12% |
| Kalos Management, Inc. | 8,500 | $244,000 | 0.11% |
| MARSHALL WACE, LLP | 550,352 | $6,423,000 | 0.10% |
| GSA CAPITAL PARTNERS LLP | 157,145 | $1,834,000 | 0.09% |